These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32197424)

  • 21. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different.
    Malnick SDH; Alin P; Somin M; Neuman MG
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease.
    Robinson KE; Shah VH
    Transl Gastroenterol Hepatol; 2020; 5():49. PubMed ID: 33073044
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Kitano A; Norikura T; Matsui-Yuasa I; Shimakawa H; Kamezawa M; Kojima-Yuasa A
    J Med Food; 2022 Oct; 25(10):982-992. PubMed ID: 36201260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
    Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
    Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review.
    Lieber CS
    Alcohol Clin Exp Res; 1999 Jun; 23(6):991-1007. PubMed ID: 10397283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.
    Schmalz F; Fischer J; Innes H; Buch S; Möller C; Matz-Soja M; von Schönfels W; Krämer B; Langhans B; Klüners A; Soyka M; Stickel F; Nattermann J; Strassburg CP; Berg T; Lutz P; Nischalke HD
    JHEP Rep; 2023 Apr; 5(4):100684. PubMed ID: 36879887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
    Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
    Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of ethanol-induced
    Grander C; Adolph TE; Wieser V; Lowe P; Wrzosek L; Gyongyosi B; Ward DV; Grabherr F; Gerner RR; Pfister A; Enrich B; Ciocan D; Macheiner S; Mayr L; Drach M; Moser P; Moschen AR; Perlemuter G; Szabo G; Cassard AM; Tilg H
    Gut; 2018 May; 67(5):891-901. PubMed ID: 28550049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments.
    Argemi J; Ventura-Cots M; Rachakonda V; Bataller R
    Rev Esp Enferm Dig; 2020 Nov; 112(11):869-878. PubMed ID: 33054302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxytyrosol attenuates ethanol-induced liver injury by ameliorating steatosis, oxidative stress and hepatic inflammation by interfering STAT3/iNOS pathway.
    Fang X; Cao J; Tao Z; Yang Z; Dai Y; Zhao L
    Redox Rep; 2023 Dec; 28(1):2187564. PubMed ID: 36932927
    [No Abstract]   [Full Text] [Related]  

  • 32. Alcohol or Gut Microbiota: Who Is the Guilty?
    Meroni M; Longo M; Dongiovanni P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
    Nagata K; Suzuki H; Sakaguchi S
    J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
    Way GW; Jackson KG; Muscu SR; Zhou H
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
    Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
    World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alcoholic liver disease].
    Waluga M; Hartleb M
    Wiad Lek; 2003; 56(1-2):61-70. PubMed ID: 12901271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [National survey of alcoholic liver disease in Japan].
    Horie Y; Ishii H; Hibi T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Dec; 39(6):505-10. PubMed ID: 15675363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects.
    Ishak KG; Zimmerman HJ; Ray MB
    Alcohol Clin Exp Res; 1991 Feb; 15(1):45-66. PubMed ID: 2059245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.